Explore / Peer-reviewed article
Peer-reviewed articleOpen access

A pilot study of cerebral metabolism and serotonin 5-HT<sub>2A</sub> receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.

Egger KiD, Gudmundsen FiD, Jessen NS, Baun CiD, Poetzsch SNiD, Shalgunov ViD, Herth MM, Quednow BBiD, Martin-Soelch CiD, Dornbierer D, Scheidegger M, Cumming P, Palner MiD

Frontiers in pharmacologySep 28, 2023License: open accessSwitzerland, Denmark, Australia17 citationsDOI: 10.3389/fphar.2023.1140656

Abstract

<b>Rationale:</b> The psychedelic effects of the traditional Amazonian botanical decoction known as ayahuasca are often attributed to agonism at brain serotonin 5-HT<sub>2A</sub> receptors by <i>N,N</i>-dimethyltryptamine (DMT). To reduce first pass metabolism of oral DMT, ayahuasca preparations additionally contain reversible monoamine oxidase A (MAO-A) inhibitors, namely β-carboline alkaloids such as harmine. However, there is lacking biochemical evidence to substantiate this pharmacokinetic potentiation of DMT in brain via systemic MAO-A inhibition. <b>Objectives:</b> We measured the pharmacokinetic profile of harmine and/or DMT in rat brain, and tested for pharmacodynamic effects on brain glucose metabolism and DMT occupancy at brain serotonin 5-HT<sub>2A</sub> receptors. <b>Methods:</b> We first measured brain concentrations of harmine and DMT after treatment with harmine and/or DMT at low sub-cutaneous doses (1 mg/kg each) or harmine plus DMT at moderate doses (3 mg/kg each). In the same groups of rats, we also measured <i>ex vivo</i> the effects of these treatments on the availability of serotonin 5-HT<sub>2A</sub> receptors in frontal cortex. Finally, we explored effects of DMT and/or harmine (1 mg/kg each) on brain glucose metabolism with [<sup>18</sup>F]FDG-PET. <b>Results:</b> Results confirmed that co-administration of harmine inhibited the formation of the DMT metabolite indole-3-acetic acid (3-IAA) in brain, while correspondingly increasing the cerebral availability of DMT. However, we were unable to detect any significant occupancy by DMT at 5-HT<sub>2A</sub> receptors measured <i>ex vivo</i>, despite brain DMT concentrations as high as 11.3 µM. We did not observe significant effects of low dose DMT and/or harmine on cerebral [<sup>18</sup>F]FDG-PET uptake. <b>Conclusion:</b> These preliminary results call for further experiments to establish the dose-dependent effects of harmine/DMT on serotonin receptor occupancy and cerebral metabolism.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

AyahuascaDMT

Keywords

Serotonin receptorHarminePsychedelicsPkpdPharmahuasca[18 F]Fdg-Pet

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

This study's objects

Directly linked records, matched by DOI, trial reference, or registry, not just topic.